Table 1 Medical monitoring of study participants
Day | Bloods | Clinical |
|---|---|---|
1 (Baseline) | FBE UEC CMP Glucose LFT’s TFT’s Vitamin D Active vitamin B12 and folate Iron studies Others as indicated (i.e. FSH, LH, estradiol/ testosterone) | Regular postural observations Temperature QID BGL ECG Overnight cardiac monitoring Medical assessment for signs of RFS |
2–7 | Daily: UEC CMP Glucose | Postural observations QID BGL ECG (Day 2 & 3) Overnight cardiac monitoring (Day 2) Medical assessment for signs of RFS |
8 onwards (as per usual protocol) | Twice Weekly: UEC CMP Glucose | Postural observations Medical assessment for signs of RFS |